UMGCCC specializes in state-of-the-art treatments and therapies for breast cancer including GammaPod, the first radiation therapy system dedicated to treating early-stage breast cancer. GammaPod patients benefit from:
Invented and developed by UMGCCC researchers and scientists, GammaPod was cleared for use in 2017 by the FDA. The University of Maryland Medical Center is the first in the world to use the new technology to treat patients.
Request a Call from an ExpertElizabeth Nichols, MD, associate professor of radiation oncology, explains a new breast cancer treatment, the GammaPod.
Invented at the University of Maryland School of Medicine, the GammaPod was designed as a faster way to treat early stage breast cancer, with less radiation reaching the heart and lungs.
William Regine, MD, Isadore & Fannie Schneider Foxman Chair of Radiation Oncology, discusses innovative treatment options for patients whose cancer has returned, including proton therapy and hyperthermia. Both available only at UMGCCC, these advanced forms of radiation offer more effective therapy in fighting tumor cells to help cure patients with recurrent cancer.